Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E25.06 EPS (ttm)6.03 Insider Own11.80% Shs Outstand908.20M Perf Week-5.07%
Market Cap145.65B Forward P/E19.16 EPS next Y7.89 Insider Trans-3.22% Shs Float955.57M Perf Month-5.48%
Income5.53B PEG2.05 EPS next Q1.59 Inst Own79.60% Short Float0.91% Perf Quarter9.42%
Sales23.09B P/S6.31 EPS this Y54.10% Inst Trans0.25% Short Ratio1.86 Perf Half Y31.89%
Book/sh3.39 P/B44.59 EPS next Y15.99% ROA14.10% Target Price156.00 Perf Year29.41%
Cash/sh1.84 P/C81.94 EPS next 5Y12.24% ROE186.80% 52W Range101.36 - 164.90 Perf YTD15.01%
Dividend2.96 P/FCF105.90 EPS past 5Y17.40% ROI24.60% 52W High-8.33% Beta0.26
Dividend %1.96% Quick Ratio0.90 Sales past 5Y2.60% Gross Margin79.20% 52W Low49.13% ATR4.36
Employees33625 Current Ratio1.10 Sales Q/Q15.10% Oper. Margin12.90% RSI (14)49.22 Volatility2.71% 2.69%
OptionableYes Debt/Eq5.60 EPS Q/Q180.20% Profit Margin24.00% Rel Volume0.50 Prev Close152.28
ShortableYes LT Debt/Eq4.54 EarningsApr 23 BMO Payout44.10% Avg Volume4.67M Price151.16
Recom2.40 SMA20-3.45% SMA502.74% SMA20017.57% Volume2,327,731 Change-0.74%
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
May-23-20 11:30AM  Why Is Lilly (LLY) Down 5.5% Since Last Earnings Report? Zacks
May-22-20 11:37AM  Better Buy: AbbVie vs. Eli Lilly Motley Fool
06:07AM  Medtronic (MDT) Q4 Earnings Miss Estimates, Revenues Beat Zacks
May-21-20 04:03PM  13 Dividend Stocks That Have Paid Investors for 100+ Years Kiplinger
02:24PM  Clovis Oncology Needs a Savior GuruFocus.com
11:30AM  Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year? Zacks
May-20-20 09:03AM  McKesson (MCK) Q4 Earnings and Revenues Surpass Estimates Zacks
07:59AM  Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist? Simply Wall St.
06:42AM  J&J to Stop Sale of Talc-Based Baby Powder in North America Zacks
May-19-20 12:46PM  AstraZeneca's Enhertu Gets Breakthrough Therapy Tag for NSCLC Zacks
09:00AM  Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Disease PR Newswire
May-18-20 10:00AM  3 Market-Beating Dividend Stocks to Buy Today Motley Fool
May-17-20 12:27PM  2 Top Diabetes Stocks to Buy in May Motley Fool
May-15-20 03:51PM  Gilead to end coronavirus drug trials, adding to access worry -researchers Reuters
02:08PM  Zacks.com featured highlights include: Clorox, Sprouts Farmers, Eli Lilly, Gold Fields and AngloGold Zacks
10:45AM  Pharma Stock Roundup: FDA Updates for LLY, AZN, MRK, BMY and SNY Zacks
10:18AM  STERIS' (STE) Q4 Earnings Surpass Estimates, Margins Rise Zacks
May-14-20 11:00PM  Biotechs harness AI in battle against Covid-19 Financial Times
07:37PM  Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)? Zacks
02:01PM  The Zacks Analyst Blog Highlights: LLY, AZN, PFE, SNY and BMY Zacks
11:51AM  Coronavirus Vaccine Progress Accelerates Yahoo Finance
10:00AM  GNC Holdings' (GNC) Q1 Earnings and Sales Miss Estimates Zacks
09:34AM  AMN Healthcare (AMN) Q1 Earnings In Line With Estimates Zacks
09:28AM  Intersect ENT (XENT) Reports Wider-Than-Expected Q1 Loss Zacks
09:27AM  Fight Off the Coronavirus Blues With 5 Low-Beta Stocks Zacks
May-13-20 07:30PM  TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma PR Newswire
10:09AM  Phibro (PAHC) Q3 Earnings Surpass Estimates, Margin Declines Zacks
10:05AM  HMS Holdings (HMSY) Earnings and Revenues Beat Estimates in Q1 Zacks
09:34AM  Drug Sector Highly Resilient Amid Coronavirus Mayhem: 5 Picks Zacks
May-12-20 10:03AM  Allscripts (MDRX) Q1 Earnings and Revenues Miss Estimates Zacks
10:00AM  National Vision (EYE) Q1 Earnings Top Estimates, Margin Falls Zacks
08:51AM  Integer Holdings (ITGR) Q1 Earnings & Revenues Top Estimates Zacks
08:36AM  ESG Stocks Remain Resilient to Virus Slump: 5 Top Picks Zacks
12:15AM  China's Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies Bloomberg
May-11-20 05:28PM  LLY Stock Approaching Support: Here Are Two Option Trade Ideas Investor's Business Daily
12:05PM  A Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside Breakout TheStreet.com
11:58AM  Zimmer Biomet (ZBH) Q1 Earnings Top, Revenues Miss Estimates Zacks
10:39AM  Insulet (PODD) Q1 Earnings Lag Estimates, Margins Decline Zacks
10:26AM  Fresenius Medical (FMS) Q1 Earnings Miss Estimates, Fall Y/Y Zacks
10:07AM  Cardinal Health (CAH) Beats Q3 Earnings and Revenue Estimates Zacks
09:52AM  LHC Group (LHCG) Earnings and Revenues Beat Estimates in Q1 Zacks
May-10-20 09:17AM  Eli Lilly Wins FDA Approval For Retevmo Lung, Thyroid Cancer Treatment SmarterAnalyst
May-09-20 10:27AM  Eli Lilly's $8 Billion Oncology Bet Gets Its Chance to Succeed Motley Fool
May-08-20 08:22PM  Lilly Receives U.S. FDA Approval for Retevmo (selpercatinib), the First Therapy Specifically for Patients with Advanced RET-Driven Lung and Thyroid Cancers PR Newswire
05:58PM  FDA approves Eli Lilly drug for thyroid, lung cancers driven by a genetic mutation Reuters
04:40PM  NIAID to Test Gilead's Remdesivir Together with Lilly's Olumiant for Coronavirus TheStreet.com
02:46PM  Government to test remdesivir with Lilly drug in COVID-19 patients MarketWatch
02:45PM  NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19 Reuters
02:20PM  Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diabetes PR Newswire
11:23AM  5 Biopharmas Where BofA Would Put Its Money To Work Benzinga
11:04AM  Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY Zacks
10:33AM  OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates Zacks
10:23AM  Globus Medical (GMED) Misses on Q1 Earnings and Revenues Zacks
10:08AM  Omnicell (OMCL) Q1 Earnings Top, Operating Margin Rises Zacks
08:59AM  Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top Zacks
08:51AM  DENTSPLY SIRONA (XRAY) Posts Weak Q1 Preliminary Results Zacks
08:50AM  Integra (IART) Lags Q1 Earnings Estimates, Withdraws Outlook Zacks
08:50AM  Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates Zacks
08:46AM  Bruker (BRKR) Q1 Earnings Miss Estimates, Guidance Suspended Zacks
08:25AM  3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline InvestorPlace
07:57AM  Pacific Biosciences (PACB) Q1 Earnings Surpass Estimates Zacks
May-07-20 11:03AM  Amedisys (AMED) Q1 Earnings Beat, Operating Margin Falls Zacks
10:40AM  QIAGEN (QGEN) Q1 Earnings Lag Estimates, Operating Margin Up Zacks
10:33AM  AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates Zacks
10:11AM  Bio-Rad (BIO) Beats Q1 Earnings Estimates, Withdraws View Zacks
10:09AM  Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands Zacks
09:14AM  Nevro (NVRO) Earnings and Revenues Beat Estimates in Q1 Zacks
09:09AM  Becton Dickinson (BDX) Q2 Earnings and Revenues Top Estimates Zacks
06:59AM  Bristol Myers sees 2020 earnings holding despite coronavirus pandemic Reuters
06:00AM  Express Scripts' 'Parachute' to cap prescription costs for those hit by coronavirus turmoil Yahoo Finance
May-06-20 07:30PM  Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer PR Newswire
11:49AM  Myriad Genetics (MYGN) Lags Q3 Earnings Estimates, Cancels View Zacks
11:48AM  CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate Zacks
11:39AM  Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View Zacks
11:33AM  Haemonetics (HAE) Q4 Earnings Lag Estimates, Margins Expand Zacks
10:51AM  Inogen's (INGN) Q1 Earnings and Revenues Beat Estimates Zacks
10:49AM  DaVita (DVA) Earnings and Revenues Beat Estimates in Q1 Zacks
10:24AM  After Its Strong First-Quarter Results, Should You Buy Shares of Eli Lilly? Motley Fool
10:23AM  PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates Zacks
09:34AM  Why These 8 Pharma Stocks Are Outplaying 90% Of The Stock Market Investor's Business Daily
May-05-20 04:50PM  The Vanguard Health Care Fund Exits CVS Health, Teva Pharmaceutical GuruFocus.com
04:30PM  Lilly to Participate in UBS Virtual Global Healthcare Conference PR Newswire
11:30AM  Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year? Zacks
11:24AM  Incyte (INCY) Misses Q1 Earnings Estimates, Beats on Revenues Zacks
11:21AM  Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates Zacks
11:00AM  Tandem Diabetes (TNDM) Q1 Loss Widens, Revenues Top Estimates Zacks
May-04-20 11:36AM  Drugmaker Eli Lilly Partners With Chinas Junshi For Covid-19 Antibody Treatment TipRanks
10:55AM  Teleflex (TFX) Earnings and Revenues Beat Estimates in Q1 Zacks
10:55AM  Hill-Rom's (HRC) Q2 Earnings Top Estimates, Margins Expand Zacks
10:26AM  Syneos Health (SYNH) Tops Q1 Earnings Estimates, Margins Down Zacks
09:14AM  Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 GlobeNewswire
08:00AM  Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 PR Newswire
May-03-20 01:26PM  Canada giving AbCellera Biologics C$176 mln for coronavirus research Reuters
May-01-20 08:52PM  Banks and Corporations Pull Back From Buybacks. Big Tech Feels Differently. Barrons.com
11:02AM  Illumina (ILMN) Beats Q1 Earnings Estimates, Withdraws View Zacks
10:48AM  3 Bullish Coronavirus Stocks to Trade Into Weakness InvestorPlace
Apr-30-20 05:31PM  Amgen Stock Jumps on Earnings, Covid-19 Trial Announcement Barrons.com
04:30PM  Lilly to Participate in Bank of America Securities Health Care Conference PR Newswire
03:40PM  Los Angeles makes coronavirus testing available Yahoo Finance Video
11:25AM  Hologic (HOLX) Beats Q2 Earnings Estimates, Withdraws View Zacks
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; and AbCellera Biologics Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerApr 27Sale163.6012,6632,071,715112,197,641Apr 28 12:21 PM
LILLY ENDOWMENT INC10% OwnerApr 24Sale162.47220,00035,743,218112,210,304Apr 27 02:36 PM
LILLY ENDOWMENT INC10% OwnerApr 23Sale160.12230,00036,826,587112,430,304Apr 27 10:39 AM
Shah Aarti S.SVP & CIOApr 14Sale150.002,000300,00019,087Apr 16 11:23 AM
LILLY ENDOWMENT INC10% OwnerApr 09Sale145.42230,00033,445,542112,660,304Apr 13 02:43 PM
LILLY ENDOWMENT INC10% OwnerApr 07Sale143.20172,31524,676,281112,890,304Apr 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerApr 06Sale142.7315,9622,278,322113,062,619Apr 07 11:40 AM
LILLY ENDOWMENT INC10% OwnerApr 03Sale143.1926,7233,826,493113,078,581Apr 06 02:42 PM
LILLY ENDOWMENT INC10% OwnerApr 02Sale140.78166,03823,374,654113,105,304Apr 03 12:42 PM
LILLY ENDOWMENT INC10% OwnerMar 31Sale140.0738,9625,457,474113,271,342Apr 01 01:47 PM
LILLY ENDOWMENT INC10% OwnerMar 30Sale139.11210,00029,213,559113,310,304Mar 31 04:03 PM
Fry Stephen FSVP, HR & DiversityMar 30Sale134.3014,6571,968,434107,415Mar 31 11:50 AM
Norton JohnaSenior VP, Global QualityMar 16Sale131.004,727619,23717,674Mar 18 10:44 AM
O'Neill MylesSVP & Pres., Mfg. OperationsMar 04Sale140.1525,0003,503,7508,469Mar 06 10:46 AM
Zakrowski Donald AChief Accounting OfficerMar 02Sale128.003,700473,6004,740Mar 03 03:27 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.00970162Feb 18 02:57 PM
LILLY ENDOWMENT INC10% OwnerFeb 05Sale146.61200,00029,321,808113,520,304Feb 06 02:27 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,317045,623Feb 04 03:59 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0069,3500226,755Feb 04 03:54 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0013,0550113,266Feb 04 03:47 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.004,896025,166Feb 04 03:44 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale138.92205,00028,478,495113,720,304Jan 14 01:37 PM
LILLY ENDOWMENT INC10% OwnerJan 10Sale138.00210,00028,979,013113,925,304Jan 13 11:00 AM
LILLY ENDOWMENT INC10% OwnerJan 09Sale135.79220,00029,874,729114,135,304Jan 10 01:45 PM
LILLY ENDOWMENT INC10% OwnerJan 08Sale133.32172,65023,018,105114,355,304Jan 09 02:04 PM
LILLY ENDOWMENT INC10% OwnerJan 07Sale132.9032,6454,338,579114,527,954Jan 08 11:33 AM
LILLY ENDOWMENT INC10% OwnerDec 20Sale132.9019,7052,618,812114,560,599Dec 23 09:48 AM
LILLY ENDOWMENT INC10% OwnerDec 18Sale129.29220,00028,443,848114,580,304Dec 19 02:36 PM
LILLY ENDOWMENT INC10% OwnerDec 17Sale125.69215,00027,023,552114,800,304Dec 18 11:31 AM
LILLY ENDOWMENT INC10% OwnerDec 09Sale119.7010,9621,312,151115,015,304Dec 10 11:49 AM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 06Sale120.0025,0003,000,00033,414Dec 10 11:56 AM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 06Sale120.004,500540,00029,306Dec 09 04:37 PM
LILLY ENDOWMENT INC10% OwnerDec 06Sale120.15194,03823,313,498115,026,266Dec 09 09:51 AM
LILLY ENDOWMENT INC10% OwnerDec 04Sale118.52210,00024,890,040115,220,304Dec 05 01:31 PM
LILLY ENDOWMENT INC10% OwnerNov 27Sale117.5148,9535,752,257115,430,304Dec 02 01:40 PM
LILLY ENDOWMENT INC10% OwnerNov 26Sale117.8156,7296,683,470115,479,257Nov 27 10:40 AM
LILLY ENDOWMENT INC10% OwnerNov 25Sale117.60109,31812,855,797115,535,986Nov 26 11:19 AM
LILLY ENDOWMENT INC10% OwnerNov 22Sale116.25251,73629,263,596115,645,304Nov 25 04:29 PM
LILLY ENDOWMENT INC10% OwnerNov 21Sale115.14108,26412,465,506115,897,040Nov 22 10:56 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.06205,00023,586,776116,005,304Nov 20 10:17 AM
LILLY ENDOWMENT INC10% OwnerNov 18Sale114.0010,5981,208,172116,210,304Nov 19 12:00 PM
LILLY ENDOWMENT INC10% OwnerNov 12Sale114.007,981909,841116,220,902Nov 13 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 11Sale114.0710011,407116,228,883Nov 12 01:12 PM
LILLY ENDOWMENT INC10% OwnerNov 07Sale114.3740045,749116,228,983Nov 08 10:35 AM
LILLY ENDOWMENT INC10% OwnerNov 06Sale114.05173,91819,835,000116,229,383Nov 07 11:03 AM
LILLY ENDOWMENT INC10% OwnerNov 04Sale114.047,003798,608116,403,301Nov 05 01:18 PM
LILLY ENDOWMENT INC10% OwnerOct 31Sale114.00190,00021,659,646116,410,304Nov 01 10:37 AM
White Anne E.SVP & Pres-Lilly OncologyOct 25Buy108.841,000108,84022,043Oct 28 03:11 PM
Smiley Joshua LSVP and CFOOct 25Buy107.5992999,95131,524Oct 28 03:06 PM
Skovronsky DanielSVP, CSO, and Pres. LRLOct 25Buy108.615,000543,05075,818Oct 28 03:00 PM
Ricks David APresident & CEOOct 25Buy108.384,615500,174157,405Oct 25 12:13 PM
TAI JACKSON PDirectorOct 24Buy107.491,861200,03956,440Oct 25 12:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 20Sale117.004,500526,50033,806Sep 23 03:54 PM
LILLY ENDOWMENT INC10% OwnerSep 20Sale116.37210,00024,437,726116,600,304Sep 23 01:33 PM
Fry Stephen FSVP, HR & DiversitySep 05Sale115.009,4521,086,980100,211Sep 09 12:12 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 03Sale112.9119,5002,201,74538,306Sep 04 03:09 PM
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM